Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MLAB logo MLAB
Upturn stock ratingUpturn stock rating
MLAB logo

Mesa Laboratories Inc (MLAB)

Upturn stock ratingUpturn stock rating
$98.67
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: MLAB (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

4 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $121.67

1 Year Target Price $121.67

Analysts Price Target For last 52 week
$121.67Target price
Low$85.59
Current$98.67
high$154.7

Analysis of Past Performance

Type Stock
Historic Profit -51.1%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 514.01M USD
Price to earnings Ratio -
1Y Target Price 121.67
Price to earnings Ratio -
1Y Target Price 121.67
Volume (30-day avg) 4
Beta 0.89
52 Weeks Range 85.59 - 154.70
Updated Date 07/1/2025
52 Weeks Range 85.59 - 154.70
Updated Date 07/1/2025
Dividends yield (FY) 0.65%
Basic EPS (TTM) -0.36

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -0.82%
Operating Margin (TTM) 2.36%

Management Effectiveness

Return on Assets (TTM) 2.5%
Return on Equity (TTM) -1.29%

Valuation

Trailing PE -
Forward PE 35.21
Enterprise Value 668926035
Price to Sales(TTM) 2.13
Enterprise Value 668926035
Price to Sales(TTM) 2.13
Enterprise Value to Revenue 2.78
Enterprise Value to EBITDA 15.8
Shares Outstanding 5455440
Shares Floating 5298430
Shares Outstanding 5455440
Shares Floating 5298430
Percent Insiders 5.98
Percent Institutions 96.44

Analyst Ratings

Rating 2
Target Price 121.67
Buy -
Strong Buy 2
Buy -
Strong Buy 2
Hold 1
Sell -
Strong Sell 1
Strong Sell 1

ai summary icon Upturn AI SWOT

Mesa Laboratories Inc

stock logo

Company Overview

overview logo History and Background

Mesa Laboratories, Inc. was founded in 1982. It provides instruments and services for quality control in regulated industries, with a focus on sterilization and other contamination control processes. The company has grown through organic development and acquisitions.

business area logo Core Business Areas

  • Sterilization and Disinfection Control: Provides sterilization indicators, equipment, and services to healthcare, pharmaceutical, and medical device industries. Includes biological indicators (BIs), chemical indicators (CIs), and monitoring systems.
  • Continuous Monitoring: Offers real-time monitoring systems for environmental parameters (temperature, pressure, humidity) in pharmaceutical and industrial applications.
  • Data Loggers: Designs and manufactures data loggers used to monitor temperature, humidity, and pressure in various applications, including pharmaceutical, food, and transportation.
  • Biopharmaceutical Development: Provides contract services for biopharmaceutical development, including assay development, cell line development, and biosafety testing.

leadership logo Leadership and Structure

The leadership team consists of the CEO, CFO, and other key executives. The organizational structure is based on business segments, with each segment having its own management team and reporting structure.

Top Products and Market Share

overview logo Key Offerings

  • Biological Indicators (BIs): Used to monitor the effectiveness of sterilization processes. Mesa Labs is a major player in the BI market. Competitors include STERIS, 3M, and Cantel Medical (now part of STERIS). Market share information is difficult to obtain precisely, but Mesa Labs is estimated to be a leading provider.
  • Market Share: Estimated to be in the top 3 providers worldwide.
  • DataTrace Data Loggers: Wireless, high-temperature data loggers used in pharmaceutical and food processing. Competitors include Vaisala and Dickson.
  • Market Share: Estimated to be in the top 3 providers worldwide.
  • Apex PRO Sterilization Verification System: An automated system for verifying the effectiveness of sterilization. Competitors include 3M, STERIS
  • Market Share: Estimated to be in the top 3 providers worldwide.

Market Dynamics

industry overview logo Industry Overview

The sterilization and contamination control market is driven by stringent regulations in healthcare, pharmaceutical, and food industries. The market is growing due to increasing awareness of infection control and the need for reliable monitoring systems.

Positioning

Mesa Labs is a leading provider of sterilization and contamination control solutions. Its competitive advantages include its reputation for quality, its wide range of products, and its strong customer relationships.

Total Addressable Market (TAM)

The total addressable market for sterilization and contamination control is estimated to be several billion USD. Mesa Labs is positioned to capture a significant share of this market with its diverse product portfolio and strong customer base.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Wide range of products and services
  • Established customer base
  • High-quality products
  • Experienced management team

Weaknesses

  • Limited geographic presence compared to larger competitors
  • Dependence on regulatory compliance
  • Smaller scale compared to larger competitors
  • Potential impact from economic downturns

Opportunities

  • Expanding into new geographic markets
  • Developing new products and services
  • Acquiring complementary businesses
  • Increasing demand for sterilization and contamination control solutions

Threats

  • Intense competition
  • Changing regulations
  • Economic downturn
  • Product liability claims

Competitors and Market Share

competitor logo Key Competitors

  • STERIS (STE)
  • 3M (MMM)
  • Cantel Medical (Now part of STERIS)

Competitive Landscape

Mesa Labs competes with larger companies like STERIS and 3M, but it has a strong reputation for quality and a loyal customer base. Mesa Labs advantages include its specialized focus and expertise in sterilization and contamination control. A disadvantage is its smaller scale compared to major competitors.

Major Acquisitions

Agena Bioscience, Inc.

  • Year: 2021
  • Acquisition Price (USD millions): 300
  • Strategic Rationale: Expand diagnostic offerings and market reach in molecular testing.

Growth Trajectory and Initiatives

Historical Growth: Mesa Labs has historically grown through organic development and strategic acquisitions.

Future Projections: Future growth projections depend on market conditions, regulatory changes, and company strategy which require access to real-time consensus estimates.

Recent Initiatives: Recent initiatives include acquisitions to expand product offerings and market presence. Specific details are unavailable without real-time access.

Summary

Mesa Labs is a reputable company within the sterilization and contamination control industry. Its strengths include a diverse product portfolio and acquisitions strategy. The company should closely monitor regulatory changes and competitive pressures. Future growth will depend on successful integration of acquisitions and expanding into new markets.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company website
  • SEC filings
  • Industry reports
  • Market research reports

Disclaimers:

This analysis is based on publicly available information and estimates. Actual results may vary. The market share data is approximate.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Mesa Laboratories Inc

Exchange NASDAQ
Headquaters Lakewood, CO, United States
IPO Launch date 1995-01-25
CEO, President & Director Mr. Gary M. Owens
Sector Technology
Industry Scientific & Technical Instruments
Full time employees 730
Full time employees 730

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.